MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 11042-64-1
MCE 国际站:γ-Oryzanol
产品活性:γ-Oryzanol 有效抑制小鼠纹状体中的 DNA 甲基转移酶 (DNMTs)。 抑制 DNMT1 和 DNMT3a,IC50 分别为 3.2 μM 和 22.3 μM。
研究领域:Epigenetics
作用靶点:DNA Methyltransferase
结构分类:酚类 | 单酚类 | 甾体类
来源:植物 | 其他科
In Vitro: γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT 3a (IC50=22.3 μM) and DNMT 3b (maximum inhibition 57%). In contrast, the inhibitory activity of Ferulic acid, a metabolite of γ-Oryzanol, is much lower than that of γ-Oryzanol. Furthermore, γ-Oryzanol acts as a partial antagonist against ERRγ, which primarily serves as a positive regulator for DNMT1 production, and consequently decreased the activity of DNMT1.
In Vivo: The brown rice-specific bioactive component γ-Oryzanol, a mixture of ferulic acid ester and several phytosterols, attenuates the preference for dietary fat via a decrease in hypothalamic endoplasmic reticulum (ER) stress. γ-Oryzanol ameliorates HFD-induced DNA hypermethylation of the promoter region of D2R in the striatum of mice. γ-Oryzanol might regulate levels of DNMTs in a striatum-specific manner. γ-Oryzanol partially decreases ERRγ activity (an approximately 40% reduction of the innate value). Oral administration of γ-Oryzanol to male mice by gavage significantly attenuates the preference for an HFD (93% of the values for vehicle-treated mice), resulting in an apparent attenuation of body weight gain.
相关产品:Natural Product Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Epigenetics Compound Library | Natural Product Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Reprogramming Compound Library | Macrocyclic Compound Library | NMPA-Approved Drug Library | Endoplasmic Reticulum Stress Compound Library | Phenols Library | FDA Approved & Pharmacopeial Drug Library | Anti-Blood Cancer Compound Library | Transcription Factor-Targeted Library | Food-Sourced Compound Library | Anti-Cancer Natural Product Library | Plant-Sourced Natural Product Library | FDA-Approved Anticancer Drug Library | Off-patent Drug Library | AA-CW236 | Psammaplin A | SGI-1027 | Bobcat339 | DNMT-IN-1 | DNMT3A-IN-1 | Decitabine | Isofistularin-3 | ZIKV-IN-3 | DC-05 | (4aS,8aR)-NPD-001 | Zebularine | 6-Thioguanine | Dihydro-5-azacytidine | DC_517 | Laccaic acid A | Lomeguatrib | GSK3735967 | Levetiracetam-d6 | O6BTG-octylglucoside | RG108 | 6-Methyl-5-azacytidine | DY-46-2 | CM-579 | 5-Azacytidine | RSC133 | Levetiracetam
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。